X0306 4 2021-11-15 0 0001642545 Shockwave Medical, Inc. SWAV 0001768265 Zacharias Isaac C/O SHOCKWAVE MEDICAL, INC. 5403 BETSY ROSS DRIVE SANTA CLARA CA 95054 0 1 0 0 Chief Commercial Officer Common Stock 2021-11-15 4 S 0 200 200.14 D 51220 D Common Stock 2021-11-15 4 S 0 400 201.09 D 50820 D Common Stock 2021-11-15 4 S 0 400 202.02 D 50420 D Common Stock 2021-11-15 4 S 0 300 203.91 D 50120 D Common Stock 2021-11-15 4 S 0 1098 205.17 D 49022 D Common Stock 2021-11-15 4 S 0 100 205.89 D 48922 D Common Stock 2021-11-15 4 S 0 702 208.26 D 48220 D Common Stock 2021-11-15 4 S 0 100 209.69 D 48120 D Common Stock 2021-11-15 4 S 0 400 211.16 D 47720 D Common Stock 2021-11-15 4 S 0 100 211.78 D 47620 D Common Stock 2021-11-15 4 S 0 200 217.69 D 47420 D All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 5/14/2021. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $199.80 to $200.48. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $200.85 to $201.32. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $202.00 to $202.07. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $203.57 to $204.33. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $204.65 to $205.51. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The reported securities were sold at a price of $205.89. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $207.89 to $208.68. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The reported securities were sold at a price of $209.69. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $210.75 to $211.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. The reported securities were sold at a price of $211.78. The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $217.68 to $217.70. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. /s/ Wade Estey, as attorney in fact for Isaac Zacharias 2021-11-16